Skip to content

JNJ

JOHNSON & JOHNSON

NYSE · Healthcare · Drug Manufacturers - General · US

$254.39
−0.46%
Ask drillr
Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open
$254.43
From 52W high
−8.63%
Volume
4.15M
Market cap
$613.05B
P/E (Fwd)
22.1x
EV/EBITDA
—
P/E (TTM)
38.6x
RSI (14)
41.6
1D Return
−0.46%
YTD Return
+22.42%
SummaryUpdated Sep 1, 2026

Johnson & Johnson (NYSE:JNJ) is one of the world's largest and most diversified healthcare companies, founded in 1886 by the Johnson brothers in New Brunswick, New Jersey. Originally starting as a manufacturer of ready-to-use sterile surgical dressings, the company has evolved over nearly 140 years into a global healthcare conglomerate. Today, J&J operates as a two-sector company focused on <b>Innovative Medicine</b> (pharmaceuticals) and <b>MedTech</b> (medical devices), having completed the spin-off of its Consumer Health division (Kenvue) in 2023. The company serves patients, healthcare professionals, and consumers across more than 175 countries worldwide, maintaining its position as a healthcare industry leader through continuous innovation and strategic acquisitions.

Similar companies

Latest newsMore news →